Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
[The cost-effectiveness of interferon beta treatment in patients with a clinically isolated syndrome in Colombia].
Isolated dysphagia due to aquaporin-4 autoimmunity.
Disease activity return after natalizumab cessation in multiple sclerosis.
Twenty years of experience on stem cell transplantation in iran.
Leukocyte counts in cerebrospinal fluid and blood following firategrast treatment in subjects with relapsing forms of multiple sclerosis.
Endocannabinoids and the Immune System in Health and Disease.
Optimization of Magnetization-Prepared 3-Dimensional Fluid Attenuated Inversion Recovery Imaging for Lesion Detection at 7 T.
Jacobian integration method increases the statistical power to measure gray matter atrophy in multiple sclerosis.
Healthcare provider beliefs about exercise and fatigue in people with multiple sclerosis.
RNA processing-associated molecular mechanisms of neurodegenerative diseases.
[Microglia in neuroimmunological disorders].
Intrinsic Functional Plasticity of the Thalamocortical System in Minimally Disabled Patients with Relapsing-Remitting Multiple Sclerosis.
Microglia: A Unique Versatile Cell in the Central Nervous System.
Celastrol Ameliorates EAE Induction by Suppressing Pathogenic T Cell Responses in the Peripheral and Central Nervous Systems.
Utility of the Canadian Treatment Optimization Recommendations (TOR) in MS Care.
Founder mutations in NDRG1 and HK1 genes are common causes of inherited neuropathies among Roma/Gypsies in Slovakia.
Low dose cyclophosphamide effectively mobilizes peripheral blood stem cells in patients with autoimmune disease.
Risk Mitigation Strategies for Adverse Reactions Associated with the Disease-Modifying Drugs in Multiple Sclerosis.
Bridging, switching or drug holidays - how to treat a patient who stops natalizumab?
Therapeutic applications of nanomedicine in autoimmune diseases: From immunosuppression to tolerance induction.
A randomized, controlled, single-blind, 6-month pilot study to evaluate the efficacy of MS-Line!: a cognitive rehabilitation programme for patients with multiple sclerosis.
Myeloid-derived suppressor cells in immunity and autoimmunity.
Bladder management in multiple sclerosis.
Molecular mechanisms of scar-sourced axon growth inhibitors.
Hippocampal-DMN disconnectivity in MS is related to WM lesions and depression.
Pages
« first
‹ previous
…
555
556
557
558
559
560
561
562
563
…
next ›
last »